About MEDIPAN
Medipan GmbH, founded in 1992 by Reinhold Hartwig and Dr. Horst Steinmaus, and GA Generic Assays GmbH, founded in 2002 by Prof. Dr. Dirk Roggenbuck, are independent family companies active in medical diagnostics, especially via immunological digital techniques for the fast & accurate diagnosis of autoimmune & infectious diseases.
Located in Ludwig-Erhard-Ring 3, 15827 Dahlewitz-Berlin, both companies are now affiliated and headed by Prof. Dr. Dirk Roggenbuck.
Medipan and GA Generic Assays GmbH specializes in the manufacture of manual detection test kits and automated systems in the following areas:
ELISA | Radioimmunoassay | Immunofluorescence assays | Lateral flow | LINE/Dot assays
Target conditions include:
Thyroid diseases | Type 1 diabetes | Rheumatoid arthritis | Polyendocrinopathies | Neuropathies | Vasculitis/Nephritis | Gastroenterology | Autoimmune hepatitis | Anti phospholipid syndrome | Complement system | Progressive systemic sclerosis | Atypical hemolytic-uremic syndrome | Pancreatitis | Systemic rheumatic inflammatory diseases | Celiac diseases | Crohn's diseases | Myasthenia gravis |
- Focus : Manufacturer
- Employees: 11-50
- Industry : Diagnostics
Here you will find MEDIPAN GmbH
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Last viewed contents
Kyphosis
Mediwatch Plc - Rugby, United Kingdom
Salicylate_sensitivity
Ketorolac
Causus_lichtensteinii
Medios AG - Berlin, Germany
PLIVA and Mayne Pharma Finalise Agreement to Continue Development of G-CSF
Epigenetic changes in blood samples may point to schizophrenia
